JNJ Consumer Sales will continue to drop with hefty penalties in South Korea for Children's Tylenol recall and India for carcinogen in baby powder.
Keywords: j&j, JNJ, johnson and johnson, johnson & johnson, south, korea, india, recall
Date Created/Edited: 2013, May 21
With consumer sales decreasing around the world, it's still not looking good for recovery of Johnson & Johnson consumer goods sales any time soon. As I noted in a previous article, Johnson & Johnson global consumer goods sales have been dropping for years. It's not a wonder. Three facilities had to be taken over by the FDA, one of which is totally shut down due to violations of FDA codes. These regulations are designed to protect consumers from companies, such as Johnson & Johnson, who do not maintain safe manufacturing facilities for our pharmaceutical supply.
Both China, in 2009, and India, in 2013, chose to remove Johnson & Johnson products from the shelves of their stores when it was discovered that they contain banned, allergenic, carcinogenic, mutagenic, ingredients. Unlike the United States government who obviously feels that the health of our American children is expendable, who simply continue to ignore the fact that there are carcinogens in baby and adult care products on the shelves of our stores. I don't know what's going on with China, but India has just begun the process of punishment for Johnson & Johnson for violating *their* regulations: they have suspended Johnson & Johnson from manufacturing certain baby products. Not exactly good for the new image of for all you love. What, pour carcinogens on our babies and ourselves? I don't think so.
After the recall of Children's Tylenol in South Korea this month, the South Korean equivalent to the United States FDA has decided on a suitable penalty for Johnson & Johnson. The company risked the health of the children of South Korea by failing to maintin proper quality control and testing of each batch. South Korea has suspended the manufacture of Children's Dye-Free Tylenol (5 months), Nizoral (4 months), Concerta (1 month), Ultacet (1 month) and Pariet (1 month). In addition, the CEO of Janssen Korea faces up to three years in prison if Johnson & Johnson is found guilty. (Resource: Janssen's Manufacturing Problems May Lead to Criminal Charges in Korea.
Add this to the recent recall in Australia of a stapling device, which can be added to all the lawsuits regarding known defective hips, and there's not going to be much improvement on the medical device sales profits after all the legal fees and settlements. The federal settlement alone on this one is over $2 billion. Also have to remember the mesh issues, another known defective device with law suits piling up.
And there are still issues with numerous drugs. Two of the worst are Risperdal and Levaquin. Geeze, there's such a backlog on the Levaquin settlements that after seven years, John Fratti has still not been offered a settlement after becoming permanantly disabled from the drug. So there goes more pharmaceutical profits.
Then, of course, there are people like me that seem to think other moms should be educated as to what's really in the products offered by Johnson & Johnson. Any mom that would knowingly allow another mom to use a product that can harm a child has got to be either cold or mentally ill.
Jeekers, boys and girls - it looks like Johnson & Johnson is not much more than corruption, lawsuits and toxic, harmful products. Oh, and Alex Gorsky, I really do think you need to resign immediately. Thanks ;o)
1. Emily Patterson (2013, May 12). Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013 Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_consumer_goods_sales.shtml
2. Dan Stanton (2013, May 20). Janssen's Manufacturing Problems May Lead to Criminal Charges in Korea in-Pharma Technologist. Retrieved from http://www.in-pharmatechnologist.com/Processing/Janssen-s-Manufacturing-Problems-May-Lead-to-Criminal-Charges-in-Korea
3. Brad Perriello (2013, May 13). Another recall for Johnson & Johnson Down Under Mass Device. Retrieved from http://www.massdevice.com/news/another-recall-johnson-johnson-down-under
4. Emily Patterson (2013, May 17). DePuy Metal on Metal Hips Dropped by Johnson & Johnson Due to Lack of Sales, Not Lack of Safety, WTF? Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mom_hips.shtml
5. Emily Patterson (2012, May 12). Johnson & Johnson Delaying $2.2 Billion DOJ Settlement to Reduce Risk of Liability to States and Victims Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_delays_settlement.shtml
6. Emily Patterson (2012, May 3). Lawsuits Mounting for Harm by Johnson & Johnson Implanted Mesh Products Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mesh.shtml
7. Emily Patterson (2012, April 13). Johnson & Johnson Risperdal: Broken Laws and Side Effects Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal.shtml
8. John Fratti. Hurt by Levaquin Levaquin Adverse Events. Retrieved from http://www.levaquinadversesideeffect.com/
9. Emily Patterson (2012, October 1). Johnson & Johnson Levaquin Victim Permanently Disabled John Fratti Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/levaquin_john_fratti.shtml
10. Emily Patterson (Current). Twenty Years of KNOWN Carcinogens in J&J US Baby Care Products Finally Ends! Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/products.shtml
11. Emily Patterson (2013, May 8). List of Reasons Johnson & Johnson CEO Alex Gorsky Should Immediately Resign Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_resignation.shtml